Login

NON-SUBSCRIBER OPTIONS
FREE TRIAL   |   NEWSSTAND

Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

FDA, Mayo Clinic and the American Red Cross have launched a nationwide expanded access program to collect and provide investigational convalescent plasma therapy to COVID-19 patients in the United States, especially those who may not have access to clinical trials.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.